US20180011102A1
University of Texas System
What is claimed is: 1 . A composition for use in treating a patient having a cancer determined to comprise: an elevated level of PGK1 S203 phosphorylation; an elevated level of PGK1 Y324 phosphorylation; an elevated level of PDHK1 T338 phosphorylation; an elevated level of PDH S293 phosphorylation;